{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:29:11Z","timestamp":1790270951498,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.clinthera.2014.10.015","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T00:37:37Z","timestamp":1416530257000},"page":"349-357","source":"Crossref","is-referenced-by-count":10,"title":["Gabapentin Enacarbil and Morphine Administered in Combination Versus Alone: A Double-blind, Randomized, Pharmacokinetic, and Tolerability Comparison"],"prefix":"10.1016","volume":"37","clinical-trial-number":[{"clinical-trial-number":"nct01476124","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Chao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Upward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thangam","family":"Arumugham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendt","family":"Stier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Davy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.10.015_bib1","unstructured":"Xenoport, Inc. Horizant US Physician\u2019s Prescribing Information. July 2013. http:\/\/www.horizant.com\/docs\/Horizant_PrescribingInformation.pdf. Accessed August 18, 2014."},{"key":"10.1016\/j.clinthera.2014.10.015_bib2","unstructured":"Pfizer. Neurontin US Physician\u2019s Prescribing Information. July 2012. http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=630. Accessed August 18, 2014."},{"key":"10.1016\/j.clinthera.2014.10.015_bib3","first-page":"613","article-title":"Clinical pharmacokinetics of gabapentin","volume":"31","author":"Bockbrader","year":"1995","journal-title":"Drugs of Today"},{"key":"10.1016\/j.clinthera.2014.10.015_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/0091270008322909","article-title":"Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin","volume":"48","author":"Cundy","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2014.10.015_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jpain.2013.01.768","article-title":"A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748)","volume":"14","author":"Zhang","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.clinthera.2014.10.015_bib6","first-page":"5","article-title":"Neurophysiology of opioid poorly responsive pain","volume":"21","author":"Dickenson","year":"1994","journal-title":"Cancer Surv"},{"key":"10.1016\/j.clinthera.2014.10.015_bib7","unstructured":"Actavis Elizabeth LLC. Kadian US Physician\u2019s Prescribing Information. July 2012. http:\/\/www.kadian.com\/NR\/rdonlyres\/E24358B1-072D-46B6-B3E2-619A6D6414BA\/0\/KadianPI_424.pdf. Accessed August 18, 2014."},{"key":"10.1016\/j.clinthera.2014.10.015_bib8","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2014.10.015_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1213\/00000539-200007000-00035","article-title":"Gabapentin enhances the analgesic effect of morphine in healthy volunteers","volume":"91","author":"Eckhardt","year":"2000","journal-title":"Anesth Analg"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814006882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814006882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:28:37Z","timestamp":1650673717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814006882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0149291814006882"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.10.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}